课题基金 / 基金详情

ELF5 integrates prolactin and progestin control of mammary gland development via regulation of progenitor cells.

ELF5 integrates prolactin and progestin control of mammary gland development via regulation of progenitor cells.
ELF5 通过调节祖细胞整合催乳素和孕激素对乳腺发育的控制。
批准号:
nhmrc : 481345
负责人:
A/Pr Matthew Naylor
金额:
$48.04万
依托单位国家:
澳大利亚
项目类别:
NHMRC Project Grants
财政年份:
2008
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2008-01-01 至 2011-12-31

项目摘要

项目成果

A/Pr Matthew Naylor的其他基金

相似基金

相关文献

中文摘要
翻译
Elf5可能是孕期乳腺细胞生长的主要调节因子。我们将证明Elf5可以取代催乳素和黄体酮来触发乳房发育,我们将确定Elf5作用于干细胞或祖细胞。最后,我们将把这些知识应用于乳腺癌细胞系,以发现Elf5在乳腺癌中的作用。这些实验有可能使Elf5成为治疗乳腺癌的新靶点。
英文摘要
Elf5 may act as a master-regulator of mammary cell growth during pregnancy. We will demonstrate that Elf5 can replace the requirement for prolactin and progesterone to trigger mammary development and we will determine the stem or progenitor cells Elf5 acts on. Finally we will apply this knowledge to breast cancer cell lines to discover what role Elf5 plays in breast cancer. These experiments have the potential to establish Elf5 as a new therapeutic target for the treatment of breast cancer.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CBFβ in breast cancer
  • 批准号:
    nhmrc : GNT1069593
  • 项目类别:
    Project Grants
  • 资助金额:
    $43.97万
  • 财政年份:
    2014
  • 负责人:
    A/Pr Matthew Naylor
  • 依托单位:
A novel role for CBF? as a regulator of breast cancer
  • 批准号:
    nhmrc : 1069593
  • 项目类别:
    Project Grants
  • 资助金额:
    $45.5万
  • 财政年份:
    2014
  • 负责人:
    A/Pr Matthew Naylor
  • 依托单位:
Role of integrin signalling in breast and prostate cancer
  • 批准号:
    nhmrc : 535904
  • 项目类别:
    Career Development Fellowships
  • 资助金额:
    $27.47万
  • 财政年份:
    2009
  • 负责人:
    A/Pr Matthew Naylor
  • 依托单位:
Characterisation of zebrafish models of muscular dystrophy
  • 批准号:
    nhmrc : 303710
  • 项目类别:
    Early Career Fellowships
  • 资助金额:
    $19.41万
  • 财政年份:
    2005
  • 负责人:
    A/Pr Matthew Naylor
  • 依托单位:
海外基金